identification serotonin/glutamate receptor complex implicated psychosis
psychosis associated schizophrenia characterized alterations sensory processing perception antipsychotic drugs identified high affinity serotonin ht2a receptors 2ar drugs interact metabotropic glutamate receptors mglur also potential treatment schizophrenia- effects hallucinogenic drugs psilocybin lysergic acid diethylamide require 2ar- resemble core symptoms schizophrenia- show mglur2 interacts specific transmembrane helix domains 2ar member unrelated g protein coupled receptor family form functional complexes brain cortex 2ar mglur2 complex triggers unique cellular responses targeted hallucinogenic drugs activation mglur2 abolishes hallucinogen specific signalling behavioural responses post mortem human brain untreated schizophrenic subjects 2ar upregulated mglur2 downregulated pattern predispose psychosis regulatory changes indicate 2ar mglur2 complex may involved altered cortical processes schizophrenia complex therefore promising new target treatment psychosis
